FibroGen, Inc. · San Francisco, CA United States
| 409 Illinois St. | Phone: 415-978-1200 |
| San Francisco, CA | Fax: 415-978-1902 |
| 94158 | |
| United States | 
Map This Company |
FibroGen, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
FibroGen is serious about drug discovery and that's no lie. The company is focused on developing and commercializing treatments for fibrosis, anemia, diabetes, and cancer, as well as producing recombinant human collagens and synthetic gelatins. FibroGen has several products in clinical development, including biotechnology (protein-based) and traditional pharmaceutical (chemical-based) candidates that could treat a variety of conditions including diabetic kidney disease, ophthalmic ailments, anemia, and cancer. The company is also researching biologic forms of human collagen for applications such as plastic surgery and drug stabilization. The company commenced lab operations in 1995.
FibroGen, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 109 |
Executives
55 executives listed for FibroGen, Inc.'s San Francisco, CA location.
| Chairman and CEO | Thomas Neff | |
|---|---|---|
| VP Finance and CFO | Pat Controneo | |
| Chief Medical Officer | Frank Valone |